The price of Tilray Brands Inc. (NASDAQ:TLRY) shares last traded on Wall Street fell -0.25% to $4.07.
As we calculate the median target price by taking the range between a high of $9.00 and a low of $2.00, we find $3.96. Given the previous closing price of $4.08, this indicates a potential downside of -2.94 percent. TLRY stock price is now 20.60% away from the 50-day moving average and -8.42% away from the 200-day moving average. The market capitalization of the company currently stands at $2.32B.
Brokers who have rated the stock have averaged $4.42 as their price target over the next twelve months.
With the price target of $3.90, Bernstein recently initiated with Mkt Perform rating for Tilray Brands Inc. (NASDAQ: TLRY). On July 29, 2022, The Benchmark Company Downgraded its previous ‘Hold’ rating to ‘Sell’ on the stock keeping its target price maintained at $3, while ‘Canaccord Genuity’ rates the stock as ‘Buy’.
In other news, Kennedy Brendan, Director sold 350,000 shares of the company’s stock on Nov 07. The stock was sold for $1,322,755 at an average price of $3.78. Upon completion of the transaction, the Director now directly owns 6,224,196 shares in the company, valued at $25.33 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 05, Director Kennedy Brendan sold 350,000 shares of the business’s stock. A total of $1,018,395 was realized by selling the stock at an average price of $2.91. This leaves the insider owning 6,574,196 shares of the company worth $26.76 million. Insiders disposed of 1,762,916 shares of company stock worth roughly $7.18 million over the past 1 year. A total of 1.50% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in TLRY stock. A new stake in Tilray Brands Inc. shares was purchased by PRENTICE CAPITAL MANAGEMENT, LP during the first quarter worth $4,303,000. CAPITAL FUND MANAGEMENT S.A. invested $1,118,000 in shares of TLRY during the first quarter. In the first quarter, BAYESIAN CAPITAL MANAGEMENT, LP acquired a new stake in Tilray Brands Inc. valued at approximately $828,000. TWINBEECH CAPITAL LP acquired a new stake in TLRY for approximately $502,000. PDT PARTNERS, LLC purchased a new stake in TLRY valued at around $442,000 in the second quarter. In total, there are 410 active investors with 11.70% ownership of the company’s stock.
A candlestick chart of Tilray Brands Inc. (NASDAQ: TLRY) showed a price of $4.0000 on Thursday morning. During the past 12 months, Tilray Brands Inc. has had a low of $2.65 and a high of $13.15. As of last week, the company has a debt-to-equity ratio of 0.14, a current ratio of 3.30, and a quick ratio of 2.40. The fifty day moving average price for TLRY is $3.3748 and a two-hundred day moving average price translates $4.4444 for the stock.
The latest earnings results from Tilray Brands Inc. (NASDAQ: TLRY) was released for Aug, 2022. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at $0.04, beating analysts’ expectations of -$0.13 by 0.17. This compares to -$0.08 EPS in the same period last year. The net profit margin was -82.90% and return on equity was -11.30% for TLRY. The company reported revenue of $153.21 million for the quarter, compared to $168.02 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -8.82 percent. For the current quarter, analysts expect TLRY to generate $247.29M in revenue.
Tilray Brands Inc.(TLRY) Company Profile
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P’tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.